The European Medicines Agency has begun evaluating an application for the use of a booster dose of Pfizer Inc./BioNTech SE’s COVID-19 vaccine, Comirnaty, to be given six months after the second dose, in people aged 16 years and older.
An accelerated assessment of data submitted by BioNTech will be carried out by the EMA’s human medicines committee, the CHMP....








